Grown Rogue International Stock Retained Earnings

Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

Based on the latest financial disclosure, Grown Rogue International has a Retained Earnings of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The retained earnings for all United States stocks is 100.0% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze Grown Rogue International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grown Rogue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grown Rogue International based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Grown Rogue financial ratios help investors to determine whether Grown OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grown with respect to the benefits of owning Grown Rogue security.